VFA
CCXI

Virtus Fund Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History

Virtus Fund Advisers’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,334
Closed -$14K – 2105
2014
Q2 		$14K Buy
+2,334
New +$13.1K ﹤0.01% 2645

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Virtus Fund Advisers's CCXI Position: Q3 2014 in Review

Virtus Fund Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q3 2014, closing a stake of 2,334 shares — an estimated $14K sold.

Virtus Fund Advisers first reported a position in CCXI in Q2 2014 and held it in 1 quarter. The position peaked at $14K in Q2 2014. 64 funds tracked by Wall St. Rank hold CCXI as of Q3 2014.

  • Virtus Fund Advisers reported no remaining ChemoCentryx, Inc. position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 2,334 ChemoCentryx, Inc. shares in Q3 2014, an estimated $14K.
  • Virtus Fund Advisers first reported a position in ChemoCentryx, Inc. in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's ChemoCentryx, Inc. position peaked at $14K in Q2 2014.
  • 64 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.